Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and

Ana Paula de Oliveira Leite1,2, Xiao C Li1,2, Sarah M Nwia1,2

  • 1Tulane Hypertension and Renal Center of Excellence, 1430 Tulane Avenue, New Orleans, LA 70112, USA.

Insights

Hypertension is a major health issue. New mouse models show that targeting specific kidney tubule genes, like AT1a receptors and NHE3, can control blood pressure and reduce hypertension risk.

Area of Science:

  • Nephrology
  • Cardiovascular Physiology
  • Genetics

Background:

  • Hypertension affects 46% of US adults, increasing risks for heart attack, stroke, and kidney disease.
  • Mechanisms of poorly controlled hypertension are not fully understood.
  • The Cre/LoxP system allows gene function studies in specific tissues.

Purpose of the Study:

  • Review findings from proximal tubule-specific genetically modified mouse models.
  • Elucidate the role of Angiotensin II (Ang II) and AT1a receptors in blood pressure regulation.
  • Investigate the impact of proximal tubule Ang II signaling on hypertension.

Main Methods:

  • Utilized Cre/LoxP technology to create mouse models with altered gene function in proximal tubules.
  • Generated models with selective deletion or overexpression of AT1a receptors and NHE3.
  • Assessed effects on basal blood pressure, pressure-natriuresis, and Ang II-induced hypertension.

Main Results:

  • Proximal tubule AT1a receptor or NHE3 deletion lowered blood pressure and enhanced natriuresis.
  • Overexpression of Ang II or AT1a receptors increased sodium reabsorption and blood pressure.
  • Hypertension development was attenuated in mice with deleted AT1a receptors or NHE3 in proximal tubules.

Conclusions:

  • Intratubular Ang II signaling via AT1a receptors and NHE3 in proximal tubules is crucial for blood pressure homeostasis.
  • Targeting these pathways in proximal tubules offers potential therapeutic strategies for hypertension.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
964
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
871
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.8K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
669
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.2K